MK-0482

DB17453InvestigationalProtein Based Therapies

MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.

Mechanism: Pharmacologically active on Leukocyte immunoglobulin-like receptor subfamily B member 4
Curator reviewed
Code names: MK-0482

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with MK-0482, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.